Corvus Pharmaceuticals (CRVS) Current Assets: 2022-2025
Historic Current Assets for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Sep 2025 value amounting to $66.9 million.
- Corvus Pharmaceuticals' Current Assets rose 55.97% to $66.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.9 million, marking a year-over-year increase of 55.97%. This contributed to the annual value of $54.4 million for FY2024, which is 94.62% up from last year.
- As of Q3 2025, Corvus Pharmaceuticals' Current Assets stood at $66.9 million, which was down 11.66% from $75.8 million recorded in Q2 2025.
- Corvus Pharmaceuticals' 5-year Current Assets high stood at $75.8 million for Q2 2025, and its period low was $22.9 million during Q1 2024.
- Its 3-year average for Current Assets is $44.7 million, with a median of $42.9 million in 2024.
- In the last 5 years, Corvus Pharmaceuticals' Current Assets plummeted by 44.77% in 2023 and then surged by 99.08% in 2025.
- Over the past 4 years, Corvus Pharmaceuticals' Current Assets (Quarterly) stood at $43.7 million in 2022, then tumbled by 35.97% to $28.0 million in 2023, then spiked by 94.62% to $54.4 million in 2024, then surged by 55.97% to $66.9 million in 2025.
- Its Current Assets stands at $66.9 million for Q3 2025, versus $75.8 million for Q2 2025 and $45.5 million for Q1 2025.